The study, published in the journal Diabetologia, examined data for 1,317 patients admitted to 53 hospitals in France between March 10 and March 31.
On the seventh day of hospitalization, researchers found that 10.3 percent had died and 20.3 percent had been intubated and placed on a ventilator in intensive care.
Most of the hospitalized patients (89 percent) had Type 2 diabetes, and nearly half (47 percent) had microvascular complications, which included damage to the eyes, kidneys and nerves. Another 41 percent had macrovascular complications, which included damage to the arteries of the heart, brain and legs.
The presence of microvascular or macrovascular complications more than doubled the risk of death within a week.
More articles on patient safety & outcomes:
COVID-19 nearly triples death risk of cancer patients, study finds
6 insights into COVID-19 patient care patterns worldwide
COVID-19 is 13 times deadlier than flu, study suggests
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
